Biomarkers in Parkinsonian Syndromes (BIOPARK)
Development of Biomarkers for the Diagnosis and Prognosis of Parkinsonian Syndromes Running Head: Biomarkers in Parkinsonian Syndromes
Sponsor: University Hospital, Bordeaux
A observational or N/A phase clinical study on Multiple System Atrophy and Parkinson's Disease, this trial is ongoing. The trial is conducted by University Hospital, Bordeaux and has accumulated 15 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Jan 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2022 — Jul 2024 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
May 2020 — Nov 2020 [monthly]
Recruiting
-
Mar 2019 — May 2020 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Aug 2017 — Mar 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Bordeaux
For direct contact, visit the study record on ClinicalTrials.gov .